Accelerating Vaccine Development Through Community-Based Pharmacy Clinical Infrastructure The partnership between WEP Clinical and RxE2 establishes a differentiated model for vaccine trial execution: one that leverages the accessibility of community pharmacies alongside global clinical [...]
A WEP Clinical White Paper With Every Patient In Recognition of International Childhood Cancer Day - February 15 Executive Summary Scientific innovation in pediatric oncology has accelerated, yet clinical trial participation among children with cancer [...]
A WEP Clinical White PaperWith Every PatientIn Recognition of World Cancer Day – February 4 Executive Summary Each year on World Cancer Day, the global oncology community reflects on both progress made and the work [...]
The FDA’s expectations around equitable access and representative enrollment in clinical research have moved from encouraged to operationally expected. With the FDA’s Enhancing Participation in Clinical Trials - Eligibility Criteria, Enrollment Practices, and Trial Designs final guidance (published December 15, [...]
